Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to start receiving our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Atopic dermatitis is a very common condition affecting dogs and often managed with allergen-specific immunotherapy, which requires accurate identification of causative allergens. Serology testing is used commonly. Serum was collected from 35 atopic dogs and separated into three samples each (1, 2,...

Author(s)
Zhou ZiJin; Pieper, J. B.; Campbell, K.
Publisher
American Animal Hospital Association, Denver, USA
Citation
Journal of the American Animal Hospital Association, 2019, 55, 3, pp 124-129
Abstract

In this pilot study, we wished to determine if C-reactive protein (CRP) levels could be a useful severity or treatment biomarker for canine atopic dermatitis (AD). Nine atopic dogs received allergen immunotherapy for 1 year. Blood was collected before and at four re-evaluation visits. At each time...

Author(s)
Favrot, C.; Fischer, N.; Rostaher, A.; Olivry, T.
Publisher
Gesellschaft Schweizer Tierärztinnen und Tierärzte GST, Bern, Switzerland
Citation
SAT, Schweizer Archiv für Tierheilkunde, 2021, 163, 1, pp 67-72
Abstract

Background: Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. allergen-specific immunotherapy (ASIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective: To retrospectively establish the efficacy of ASIT ...

Author(s)
Fennis, E. E. M.; Damme, C. M. M. van; Schlotter, Y. M.; Sinke, J. D.; Leistra, M. H. G.; Bartels, R. T.; Broere, F.
Publisher
Wiley, Oxford, UK
Citation
Veterinary Dermatology, 2022, 33, 4, pp 321-328, e74-e75
Abstract

Canine atopic dermatitis (cAD) is a chronic and recurrent inflammatory and pruritic skin disease in dogs. Currently, allergen-specific immunotherapy (ASIT) is the only identified disease-modifying intervention for allergic diseases. It decreases the symptoms triggered by allergens and prevents...

Author(s)
Majewska, A.; Dembele, K.; Dziendzikowska, K.; Prostek, A.; Gajewska, M.
Publisher
MDPI AG, Basel, Switzerland
Citation
Vaccines, 2022, 10, 7,
Abstract

Background: Serum testing for allergen-specific immunoglobulin (Ig)E is commonly employed to identify allergens used for allergen-specific immunotherapy in dogs, yet the reliability of results has been a matter of debate. Objective: The aim of this study was to evaluate the reproducibility of serum ...

Author(s)
Baumann, K. N.; Gedon, N. K. Y.; Boehm, T. M. S. A.; Udraite-Vovk, L.; Mueller, R. S.
Publisher
Wiley, Oxford, UK
Citation
Veterinary Dermatology, 2021, 32, 3, pp 251-e67
Abstract

Background: A recent pilot study of primary care veterinarians' attitudes regarding canine atopic dermatitis and initiation of allergen-specific immunotherapy (ASIT) revealed several barriers to specialist referral (in the USA) and use of ASIT as a treatment modality. Hypothesis/Objectives: The...

Author(s)
Flanagan, S.; Schick, A.; Lewis, T. P.; Tater, K. C.; Rishniw, M.
Publisher
Wiley, Oxford, UK
Citation
Veterinary Dermatology, 2020, 32, 2, pp 106-e21
Abstract

Background: While the efficacy of allergen-specific immunotherapy (ASIT) to treat canine atopic dermatitis has been well established, it remains unclear why not all dogs show the same response to treatment. The goal of the study was to determine the relationship between duration of ASIT and two...

Author(s)
Ramió-Lluch, L.; Brazís, P.; Ferrer, L.; Puigdemont, A.
Publisher
BMJ Publishing Group, London, UK
Citation
Veterinary Record, 2020, 187, 12, pp 493-493
Abstract

Background: Dermatophagoides farinae is a major and common environmental house dust mite involved in canine atopic dermatitis (CAD). A formulation of recombinant protein Der f 2 is available in Japan for immunotherapy in dogs. Hypothesis/Objectives: To evaluate the efficacy of a recombinant...

Author(s)
Kawano, K.; Mizuno, T.
Publisher
Wiley, Oxford, UK
Citation
Veterinary Dermatology, 2017, 28, 6, pp 583-e141
Abstract

Food allergen-specific sublingual immunotherapy (FA-SLIT) is a novel, safe and effective approach in dogs with adverse food reactions (AFR) to reduce their clinical symptoms. However, little is known about the specific immune components which mediate this reduction in clinical symptoms. In humans,...

Author(s)
Maina, E.; Devriendt, B.; Cox, E.
Publisher
Elsevier B.V., Amsterdam, Netherlands
Citation
Veterinary Immunology and Immunopathology, 2019, 212, pp 38-42
Abstract

Objective: To determine the prevalence of positive allergen reactions in intradermal and IgE serological tests in dogs presenting to a dermatology referral centre in South Australia and the clinical efficacy of subsequent allergen-specific immunotherapy. Design: Retrospective study. Methods:...

Author(s)
Han, C.; Chan, W. Y.; Hill, P. B.
Publisher
Wiley, Melbourne, Australia
Citation
Australian Veterinary Journal, 2020, 98, 1/2, pp 17-25

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics